These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38968665)

  • 1. Medication refractory restless legs syndrome: Real-world experience.
    Petramfar P; Jankovic J
    J Neurol Sci; 2024 Aug; 463():123121. PubMed ID: 38968665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.
    Hankin C; Lee D; Garcia-Borreguero D; Wang Z
    J Clin Sleep Med; 2019 Sep; 15(9):1225-1232. PubMed ID: 31538593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of restless legs syndrome with dopamine agonists.
    Ondo W; Romanyshyn J; Vuong KD; Lai D
    Arch Neurol; 2004 Sep; 61(9):1393-7. PubMed ID: 15364685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in dopamine agonists prescribing and characteristics of drugs prescribed during ambulatory office visits for restless legs syndrome: the National Ambulatory Medical Care Survey 2007-2015.
    Kim J; Hartzema AG
    Sleep Med; 2019 Feb; 54():238-243. PubMed ID: 30590306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.
    Voon V; Schoerling A; Wenzel S; Ekanayake V; Reiff J; Trenkwalder C; Sixel-Döring F
    BMC Neurol; 2011 Sep; 11():117. PubMed ID: 21955669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
    Wang T; Ying M; Zhao R; Zhu D; Zhang L
    Sleep Breath; 2022 Mar; 26(1):373-380. PubMed ID: 33864178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restless legs syndrome in Parkinson's disease: relationship with quality of life and medication.
    Minar M; Kosutzka Z; Danterova K; Gmitterova K; Straka I; Kusnirova A; Tosecka R; Juricek R; Kloc M; Wyman-Chick KA; Valkovic P
    Bratisl Lek Listy; 2022; 123(1):55-60. PubMed ID: 34967659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Safety, Dose Stability, and Efficacy of Opioids for Patients With Restless Legs Syndrome in the National RLS Opioid Registry.
    Winkelman JW; Wipper B; Zackon J
    Neurology; 2023 Apr; 100(14):e1520-e1528. PubMed ID: 36697248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
    Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
    Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restless legs syndrome - a review].
    Sveinsson OA; Sigurdsson AP
    Laeknabladid; 2012 Jan; 98(1):33-7. PubMed ID: 22253081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actigraphic assessment of periodic leg movements in patients with restless legs syndrome.
    Cippà MA; Baumann CR; Siccoli MM; Bassetti CL; Poryazova R; Werth E
    J Sleep Res; 2013 Oct; 22(5):589-92. PubMed ID: 23530689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Pressure on Abductor Hallucis and Flexor Hallucis Brevis Muscles to Manage Moderate to Severe Primary Restless Legs Syndrome.
    Kuhn PJ; Olson DJ; Sullivan JP
    J Am Osteopath Assoc; 2016 Jul; 116(7):440-50. PubMed ID: 27367949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ; Wall CA; Angstman ER; Munitz GE; Kotagal S
    J Clin Sleep Med; 2011 Dec; 7(6):587-96. PubMed ID: 22171196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.